The AJMC® COPD compendium is a comprehensive resource for clinical news and expert insights for chronic obstructive pulmonary disease.
May 7th 2024
There is an extremely low rate of chronic obstructive pulmonary disease (COPD) diagnoses in Japan, particularly among patients with airflow obstruction, despite regular respiratory function tests.
Evolving Treatment Strategies in the Management of Pulmonary Arterial Hypertension: Key Insights for the Pharmacist, featuring a Patient Perspective
1.5 Credits / Pulmonology/Respiratory
View More
Advances in EGFR Exon 20 Insertion-Positive Non–Small Cell Lung Cancer: A Focus on Specialty Pharmacy Interventions
1.5 Credits / Oncology, Pulmonology/Respiratory
View More
Advances and Best Practices for Managed Care Pharmacists and the Treatment of Patients with Alpha-1 Antitrypsin Deficiency
1.0 Credit / Pulmonology/Respiratory
View More
Identifying the Inability to Heal Lungs in COPD
December 29th 2016Although chronic obstructive pulmonary disease (COPD) remains a leading cause of death around the world, the reason for why patients with COPD lose the ability to repair damage to their lungs is poorly defined. However, researchers at the Helmholtz Zentrium München may now have an idea of why this happens.
Read More
Racial and Gender Disparities in COPD Risk for Never-Smokers
December 17th 2016A study on gender and racial inequalities in the prevalence of chronic obstructive pulmonary disease among non-smokers found that black Americans and women are at higher risk, possibly due to a combination of biological and social factors.
Read More
Allison Silvers Discusses How Innovative Funding Models Can Drive Demand for Palliative Care
December 11th 2016Innovative funding models like value-based payments can change providers’ incentives and drive them to seek solutions like palliative care, said Allison Silvers, vice president of payment and policy at the Center to Advance Palliative Care.
Watch
Renee Murray Explains How Hotspotting Is Used
October 21st 2016The hotspotting technique that Camden Coalition of Healthcare Providers uses to care for complex patients shifts away from breaking people into segments based on disease, and looks at the whole make up of a person, considering every disease or social complexity that may be in effect, explained Renee Murray, associate clinical director of Care Management Initiatives at Camden Coalition.
Watch
Association of Part D Coverage Gap With COPD Medication Adherence
Using longitudinal Medicare claims data, this study quantified the association of the Medicare Part D coverage gap with medication adherence among beneficiaries with chronic obstructive pulmonary disease.
Read More
Dr Steven Pearson Outlines Specialty Conditions Impacting Healthcare Spending
April 19th 2016Steven D. Pearson, MD, president of the Institute for Clinical and Economic Review, discussed the specialty conditions that are having the biggest impact on overall healthcare expenditures and pharmaceutical spending.
Watch
Physical Activity Tied to Lower Risk of Mortality After COPD Hospitalization
April 4th 2016Patients with chronic obstructive pulmonary disease (COPD) who engage in greater amounts of physical activity in the 12 months prior to hospitalization for COPD have a lower risk of death in the year following discharge.
Read More
Cleveland Clinic Data: Heart Attack Patients Getting Younger, Fatter
March 26th 2016Data showed that patients coming to the world-famous hospital for a heart attack grew younger, sicker, and more obese from 1995 to 2014. Because the researchers have not yet reported socioeconomic status, it is hard to know whether the findings reflect broader trends.
Read More
What We're Reading: Moderate Drinking May Have No Health Benefits
March 23rd 2016What we're reading, March 23, 2016: moderate alcohol consumption may not have any health benefits; Johnson & Johnson researching the development of 2 diseases; and 2 more California hospitals received ransom demands from hackers.
Read More
Acetazolamide's Effect on Mechanical Ventilation Duration in COPD Patients
March 3rd 2016Study finds no statistically significant duration in the use of mechanical ventilation for patients with chronic obstructive pulmonary disease who took acetazolamide, but there was a clinically significant difference.
Read More
Organizational Structure for Chronic Heart Failure and Chronic Obstructive Pulmonary Disease
In a nationwide cross-sectional comparison of organizational structure for chronic disease management, less attention was given to chronic obstructive pulmonary disease than chronic heart failure.
Read More
COPD Exacerbation Frequency Not Associated With Stroke
February 18th 2016While patients with chronic obstructive pulmonary disease have a higher risk of stroke than the general population, patients who have frequent exacerbations of their illness actually have a reduced risk of stroke than those with infrequent exacerbations.
Read More
Cognitive Impairment and Reduced Early Readmissions in Congestive Heart Failure?
Proactive identification of cognitive impairment and compensatory destigmatized patient/familial psychoeducation regarding “forgetfulness” in hospitalized patients with congestive heart failure may reduce readmission rates substantially.
Read More
Predicting COPD Exacerbations With Primary Care Data
November 18th 2015Although, data on predictive risk factors for chronic obstructive pulmonary disease has been limited until now, researchers from the United Kingdom recently developed a model for predicting exacerbation risk using data obtainable from primary care.
Read More
Improving COPD Management Through Use of Patient EMR Information
November 9th 2015Using information in a patient's electronic medical record during outpatient visits for patients with chronic obstructive pulmonary disease can lead to better outcomes, according to a study in Respiratory Medicine.
Read More
Novartis COPD Dual Combination Bronchodilator Approved
October 31st 2015Novartis' dual combination bronchodilator Utibron Neohaler inhalation powder for patients with chronic obstructive pulmonary disease (COPD) has received FDA approval. It is not indicated to treat asthma or sudden symptoms of COPD.
Read More